Search

everythinglearnresearchcommunity

for

Search:↓

New insights into cell communication in psoriasis suggest innovative drug treatments.

Chronic Telogen Effluvium may resolve after years and is diagnosed by examining the patient's history and clinical signs, with treatment aimed at underlying causes and possibly minoxidil.

Estrogen therapy can reduce skin aging but has cancer risks.

Genetic variations in hair keratin proteins exist but don't significantly affect hair structure.

Stress may contribute to hair loss in alopecia areata by affecting immune responses and cell death in hair follicles.

Nanotechnology could improve hair regrowth but faces challenges like complexity and safety concerns.

Skin aging is due to impaired stem cell mobilization or fewer responsive stem cells.

Platycladus orientalis leaf extract helps hair grow by activating certain proteins.

Light therapy might help treat hereditary hair loss by improving hair follicle growth in lab cultures.

DHT, a testosterone byproduct, causes male pattern baldness.

SIRT7 protein is crucial for starting hair growth in mice.

Horizontal sections of scalp biopsies are good for diagnosing Central Centrifugal Cicatricial Alopecia and help customize treatment.

Telogen Effluvium is a condition causing excessive hair loss due to stress, illness, drugs, or hormonal changes, and can be treated with specific products or naturally resolves after 3-4 years.

The herbal mix (Biochanin A, Acetyl tetrapeptide-3, and Ginseng Extracts) and the 3% Minoxidil solution are equally effective in treating hair loss, but the herbal mix has fewer side effects.

Beard cells, unlike scalp cells, produce growth factors in response to testosterone, which may explain differences in hair growth.

Human skin acts like a hormone-producing organ, making and managing various hormones important for skin and hair health.

Stem cell therapies show promise for hair regrowth in androgenetic alopecia.

Skin stem cells interacting with their environment is crucial for maintaining and regenerating skin and hair, and understanding this can help develop new treatments for skin and hair disorders.

Dlx3 is essential for hair growth and regeneration.

FGF13 gene changes cause excessive hair growth in a rare condition.

A specific genetic change in the KRT71 gene causes a hair loss condition in Hereford cattle.

Platelet-Rich Plasma therapy helps increase hair density and regrowth for some types of hair loss.

PAD3 plays a key role in hair and skin protein structure and may be linked to skin diseases.

Eosinophilic infiltrate is not a reliable indicator for diagnosing chronic alopecia areata.

Trichoscopy helps tell apart Frontal Fibrosing Alopecia and Lichen planopilaris by showing different hair and scalp features.

Treating hair loss effectively may require a multi-sided approach, using different treatments together, and topical treatments could be more effective and safer than oral ones.

The document concludes that understanding hair follicle histology and the hair cycle is crucial for diagnosing alopecia.

Retinoic acid-binding proteins in skin are regulated by β-catenin and Notch signalling.

Alopecia areata and vitiligo share immune system dysfunction but differ in specific immune responses and affected areas.

TGM3 is important for skin and hair structure and may help diagnose cancer.